Isavuconazole for Mold Infections in Pediatric Patients

ClinicalTrials.gov Identifier: NCT01731353

FungiScope® is and has been receiving unrestricted grants from:
Amplyx Pharmaceuticals Inc., Basilea Pharmaceutica, Cidara Therapeutics Inc., F2G Biotech GmbH, Matinas BioPharma Holdings Inc., Mundipharma Ltd., Pfizer Inc.

Imprint , Privacy Policy

FungiScope® - Global Invasive Fungal Infection Registry
50937 Cologne, Germany
Email: fungiscope[at]uk-koeln.de
www.fungiscope.net

Powered by WP – Designed with the Customizr theme